StemCell Therapy

DUBLIN--(BUSINESS WIRE)--The "Global Point of Care (PoC) Molecular Diagnostics Market 2020-2030 by Product (Assays, Instruments, Software), Technology (PCR, INAAT, Microarray), Application, End User, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

The global PoC molecular diagnostics market will reach $5,665.3 million by 2030, growing by 13.5% annually over 2020-2030 driven by increase in adoption of personalized medicine and surge in usage of PoC molecular diagnostics for drug discovery and development amid COVID-19 pandemic.

This report is based on a comprehensive research of the entire global PoC molecular diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global PoC molecular diagnostics market in every aspect of the classification from perspectives of Product, Technology, Application, End User, and Region.

Key Players:

Key Topics Covered:

1 Introduction

1.1 Industry Definition and Research Scope

1.1.1 Industry Definition

1.1.2 Research Scope

1.2 Research Methodology

1.2.1 Overview of Market Research Methodology

1.2.2 Market Assumption

1.2.3 Secondary Data

1.2.4 Primary Data

1.2.5 Data Filtration and Model Design

1.2.6 Market Size/Share Estimation

1.2.7 Research Limitations

1.3 Executive Summary

2 Market Overview and Dynamics

2.1 Market Size and Forecast

2.1.1 Impact of COVID-19 on World Economy

2.1.2 Impact of COVID-19 on the Market

2.2 Major Growth Drivers

2.3 Market Restraints and Challenges

2.4 Emerging Opportunities and Market Trends

2.5 Porter's Five Forces Analysis

3 Segmentation of Global Market by Product

3.1 Market Overview by Product

3.2 Kits & Assays

3.3 Analyzers & Instruments

3.4 Software & Services

4 Segmentation of Global Market by Technology

4.1 Market Overview by Technology

4.2 Polymerase Chain Reaction (PCR)

4.2.1 Real-Time PCR (rt-PCR)

4.2.2 Digital PCR (d-PCR)

4.3 Isothermal Nucleic Acid Amplification Technology (INAAT)

4.4 Genetic Sequencing-based Technology

4.5 Microarray-based Technology

4.6 Other Technologies

5 Segmentation of Global Market by Application

5.1 Market Overview by Application

5.2 Infectious Disease

5.2.1 Respiratory Infections

5.2.2 Hospital Acquired Infections

5.2.3 Sexually Transmitted Infections

5.3 Gastrointestinal Infections

5.4 Oncology

5.5 Hepatitis

5.6 Prenatal/Neonatal Testing

5.7 Other Applications

6 Segmentation of Global Market by End User

6.1 Market Overview by End User

6.2 Hospitals

6.3 Clinics & Diagnostic Centers

6.4 Research and Academic Institutes

6.5 Other End Users

7 Segmentation of Global Market by Region

7.1 Geographic Market Overview 2019-2030

7.2 North America Market 2019-2030 by Country

7.2.1 Overview of North America Market

7.2.2 U.S.

7.2.3 Canada

7.2.4 Mexico

7.3 European Market 2019-2030 by Country

7.3.1 Overview of European Market

7.3.2 Germany

7.3.3 UK

7.3.4 France

7.3.5 Spain

7.3.6 Italy

7.3.7 Russia

7.3.8 Rest of European Market

7.4 Asia-Pacific Market 2019-2030 by Country

7.4.1 Overview of Asia-Pacific Market

7.4.2 Japan

7.4.3 China

7.4.4 Australia

7.4.5 India

7.4.6 South Korea

7.4.7 Rest of APAC Region

7.5 South America Market 2019-2030 by Country

7.5.1 Argentina

7.5.2 Brazil

7.5.3 Chile

7.5.4 Rest of South America Market

7.6 MEA Market 2019-2030 by Country

7.6.1 UAE

7.6.2 Saudi Arabia

7.6.3 South Africa

7.6.4 Other National Markets

8 Competitive Landscape

8.1 Overview of Key Vendors

8.2 New Product Launch, Partnership, Investment, and M&A

8.3 Company Profiles

9 Investing in Global Market: Risk Assessment and Management

9.1 Risk Evaluation of Global Market

9.2 Critical Success Factors (CSFs)

Originally posted here:
Worldwide Point of Care (PoC) Molecular Diagnostics Industry to 2030 - Impact Analysis of COVID-19 - ResearchAndMarkets.com - Business Wire

This entry was posted on February 17, 2021 at 1:54 am and is filed under Personalized Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |